Literature DB >> 15664383

Growth factor signal transduction defects in the cardiovascular system.

Johannes Waltenberger1.   

Abstract

Growth factors are important molecules mediating both the development as well as adaptive and pathological changes within the cardiovascular system. Growth factors therefore mediate both beneficial and nonbeneficial effects. The beneficial actions include the improvement of endothelial function, stimulation of vascular repair, the formation of new capillaries (angiogenesis), and the growth of collateral arteries (arteriogenesis). These actions represent the conceptual basis for the therapeutic use of growth factors, based on the idea to therapeutically induce or accelerate a given beneficial process. The beneficial effects of growth factors have to be separated from effects where growth factors act as mediators of pathological processes such as atherogenesis and plaque destabilization. This review article focuses on the physiological and beneficial effects of growth factors in the vessel wall and describes and explains the dysfunction of these effects under certain conditions now referred to as "growth factor signal transduction defects".

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664383     DOI: 10.1016/j.cardiores.2004.11.001

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling.

Authors:  G Doronzo; I Russo; L Mattiello; C Riganti; G Anfossi; M Trovati
Journal:  Diabetologia       Date:  2006-02-28       Impact factor: 10.122

2.  Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density.

Authors:  Luana Anjos-Ramos; Marcela S Carneiro-Ramos; Gabriela P Diniz; Joelcimar Martins-Silva; Maria Luiza Morais Barreto-Chaves
Journal:  Virchows Arch       Date:  2006-01-27       Impact factor: 4.064

3.  PTP1B inhibitor promotes endothelial cell motility by activating the DOCK180/Rac1 pathway.

Authors:  Yuan Wang; Feng Yan; Qing Ye; Xiao Wu; Fan Jiang
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

4.  Protein tyrosine phosphatases in cell adhesion.

Authors:  Katherine A Young; Laura Biggins; Hayley J Sharpe
Journal:  Biochem J       Date:  2021-03-12       Impact factor: 3.857

5.  Impaired collateral recruitment and outward remodeling in experimental diabetes.

Authors:  Jolanda M van Golde; Matthijs S Ruiter; Nicolaas C Schaper; Stefan Vöö; Johannes Waltenberger; Walter H Backes; Mark J Post; Maya S Huijberts
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.